Dr. Lirim Krveshi, DO Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 Hospital Ln Ste 303, Danville, IN 46122 Phone: 317-718-4000 Fax: 317-718-4005 |
Sami Abuqayyas, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 Hospital Ln Ste 303, Danville, IN 46122 Phone: 317-718-4000 Fax: 317-718-4005 |
News Archive
University of Michigan researchers are testing a new procedure in which they can take a tiny piece of a person's mouth lining, grow it into a dollar-bill sized piece of tissue and graft that expanded piece into the donor's mouth to heal a wound.
Wealthy, white California counties-once considered the nation's hotbeds for autism spectrum disorder (ASD)-have seen prevalence flatten or fall in the last two decades, while rates among poor whites and minorities keep ticking up, new CU Boulder research has found.
Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.
Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi's sarcoma and primary effusion lymphoma (PEL). PELs are aggressive lymphomas with reported median survival time shorter than six months after diagnosis.
› Verified 8 days ago